Fact-checked by Grok 2 weeks ago

Bicarbonate buffer system

The bicarbonate buffer system is the principal physiological mechanism for maintaining acid-base balance in the and extracellular fluids, operating through the reversible CO₂ + H₂O ⇌ H₂CO₃ ⇌ H⁺ + HCO₃⁻ to neutralize excess acids or bases and stabilize at approximately 7.4. This system relies on the conjugate acid-base pair of (H₂CO₃) and bicarbonate ion (HCO₃⁻), with the reaction catalyzed by the enzyme primarily in red cells, allowing rapid adjustments to fluctuations caused by metabolic processes such as production or CO₂ generation. As the most abundant buffer in , with normal plasma concentrations of approximately 24 mmol/L for and 1.2 mmol/L for dissolved CO₂, the system has a buffering capacity exceeding that of other plasma buffers like , though provides significant buffering in blood. Its effectiveness stems from being an open buffer system, where volatile CO₂ can be continuously produced from cellular metabolism and excreted via the lungs, enabling dynamic regulation independent of closed intracellular buffers. In , excess H⁺ shifts the equilibrium toward CO₂ formation and exhalation, while in , reduced CO₂ loss promotes H⁺ retention; this maintains a typical HCO₃⁻:H₂CO₃ ratio of 20:1 under normal conditions. The system's integration with respiratory and renal physiologies amplifies its role: the lungs adjust to control CO₂ levels within minutes, while the kidneys reabsorb or generate HCO₃⁻ over hours to days, ensuring long-term stability essential for enzymatic function, oxygen transport, and overall . Disruptions, such as in respiratory or metabolic disorders, can lead to imbalances like or , underscoring its critical importance in preventing cellular dysfunction.

Chemical Basis

Core Equilibrium Reactions

The bicarbonate buffer system functions as an open buffer primarily through the reversible equilibrium reaction in which (CO₂) combines with (H₂O) to form (H₂CO₃), which subsequently dissociates into hydrogen ions (H⁺) and bicarbonate ions (HCO₃⁻): \text{CO}_2 + \text{H}_2\text{O} \rightleftharpoons \text{H}_2\text{CO}_3 \rightleftharpoons \text{H}^+ + \text{HCO}_3^- This equilibrium is fundamental to acid-base in biological fluids. The of CO₂ to H₂CO₃ is a slow uncatalyzed process, but it is greatly accelerated by the , which catalyzes the interconversion between CO₂, H₂O, H₂CO₃, H⁺, and HCO₃⁻, enabling rapid response to changes. The key components of the system are dissolved CO₂ (whose concentration is proportional to its , PCO₂, via ), carbonic acid (H₂CO₃), the ion (HCO₃⁻), and hydrogen ions (H⁺). These interact dynamically, with H₂CO₃ existing in low concentrations due to its and rapid . Unlike closed systems, where components are fixed and limited, the is an "open" system because CO₂ is a volatile gas that can be continuously added or removed (e.g., via ), preventing and allowing indefinite buffering capacity as long as CO₂ levels are adjustable. The dissociation step, H₂CO₃ ⇌ H⁺ + HCO₃⁻, is governed by the , which defines the K_a as: K_a = \frac{[\text{H}^+][\text{HCO}_3^-]}{[\text{H}_2\text{CO}_3]} This determines the ratio of dissociated to undissociated forms at any given , with the second step being rapid and typically at under physiological conditions.

Buffer Properties and pKa Value

The bicarbonate buffer system exhibits an apparent of approximately 6.35 at 25°C and 6.1 at 37°C for the H₂CO₃ ⇌ H⁺ + HCO₃⁻, reflecting the of into its conjugate base and proton. In physiological conditions at 37°C, the system's effective buffering range extends toward the of 7.0–7.4 due to the coupled CO₂ (CO₂ + H₂O ⇌ H₂CO₃), where the true concentration of H₂CO₃ is very low (~0.3% of dissolved CO₂), and the predominant is dissolved CO₂, allowing the system to maintain a high [HCO₃⁻]/[H₂CO₃] ratio of about 20:1. This coupling enhances the buffer's responsiveness at physiological despite the pKa-pH mismatch typical of closed systems. The buffer capacity (β), defined as the amount of strong acid or base added per unit change in (β = dB/dpH, in units of mmol/L/), quantifies the system's resistance to shifts and is notably high in owing to the elevated concentration of 24–28 mEq/L. For at 7.4, the overall buffer capacity is approximately 16–30 mmol/L/, with contributing substantially through its abundance and linkage to respiratory CO₂ regulation. This capacity enables the system to neutralize added acids or bases effectively, such as during metabolic perturbations, by shifting the to consume or produce H⁺. As the primary extracellular buffer, the bicarbonate system accounts for roughly 50% of the total buffering power in and interstitial fluid, outperforming other extracellular components like plasma proteins and due to its higher concentration and open-system dynamics. In contrast, intracellular buffering relies predominantly on buffers (pKa ~7.2 for H₂PO₄⁻/HPO₄²⁻) and proteins, including hemoglobin's groups (pKa ~7.0), which handle ~75% of whole-blood buffering but are compartmentalized within cells. This extracellular-intracellular distinction underscores 's specialized role in maintaining systemic stability. Several factors modulate the bicarbonate system's capacity, including temperature, which decreases the pKa by ~0.02 units per °C rise, thereby influencing equilibrium positioning; ionic strength, which alters ion activities and dissociation constants via Debye-Hückel effects; and PCO₂ levels, which directly impact [H₂CO₃] and thus the buffer ratio through Henry's law solubility. These variables ensure adaptability under varying physiological states, such as fever or hypoxia, without compromising overall efficiency.

Systemic Physiological Role

Importance in Blood pH Homeostasis

The bicarbonate buffer system plays a central role in maintaining arterial blood pH within the narrow physiological range of 7.35 to 7.45, essential for optimal enzyme function, oxygen transport, and cellular metabolism. Daily metabolic processes generate substantial acid loads, including approximately 13,000 mmol of volatile acid from CO₂ production and about 80 mmol of non-volatile acids (such as sulfuric and phosphoric acids from protein and phospholipid metabolism), which the system neutralizes to prevent significant pH deviations. Through the core equilibrium reactions involving carbonic acid (H₂CO₃), bicarbonate (HCO₃⁻), and CO₂, excess hydrogen ions (H⁺) bind to HCO₃⁻ to form H₂CO₃, which rapidly dissociates into CO₂ and water, allowing the volatile component to be exhaled and thereby stabilizing pH. This system interacts synergistically with other blood buffers, such as and , to enhance overall buffering capacity; for instance, during CO₂ transport from tissues to lungs, approximately 70% of CO₂ is converted to HCO₃⁻ within red blood cells, with deoxygenated buffering the released H⁺ to facilitate this process and prevent intracellular acidification. Phosphate buffers contribute minimally in blood (about 5% of total capacity) but support the bicarbonate system in , collectively ensuring that the bicarbonate pathway handles the majority of metabolic acid buffering without overwhelming closed intracellular systems. Imbalances in this system lead to acid-base disorders with profound physiological consequences; (pH < 7.35) impairs cardiac contractility, reduces oxygen delivery to tissues, and triggers compensatory hyperventilation to expel excess CO₂, while alkalosis (pH > 7.45) causes neuromuscular irritability, muscle cramps, and induces to retain CO₂ and lower . These disruptions highlight the system's indispensability, as even minor shifts can compromise and organ function. The bicarbonate buffer's effectiveness stems from its nature as an open , uniquely suited for rapid adaptation to fluctuating metabolic demands; unlike closed buffers limited by fixed concentrations, it links directly to respiratory elimination of CO₂, providing virtually unlimited capacity to regenerate HCO₃⁻ and respond dynamically to acid loads without pH drift. This evolutionary adaptation ensures efficient handling of the body's high-volume acid production, prioritizing quick equilibration over the slower kinetics of renal or intracellular mechanisms.

Respiratory and Renal Regulation

The bicarbonate buffer system is dynamically regulated by the respiratory and renal systems to maintain blood homeostasis, with each organ responding to acid-base disturbances through adjustments in of carbon dioxide (PCO₂) and (HCO₃⁻) levels, respectively. The primarily controls PCO₂ via alveolar ventilation, where the normal arterial PCO₂ is maintained at approximately 40 mmHg. In response to , rapidly lowers PCO₂, shifting the equilibrium to reduce H⁺ concentration and raise pH; conversely, elevates PCO₂ during to increase formation and lower pH. This ventilatory adjustment occurs within minutes to hours, providing acute compensation for metabolic disturbances. The kidneys exert longer-term control by regulating HCO₃⁻ and , handling a filtered load of approximately 4,500 mEq of HCO₃⁻ per day under normal conditions. In the , about 80-90% of filtered HCO₃⁻ is reabsorbed through H⁺ secretion via Na⁺/H⁺ exchangers and activity, which converts luminal HCO₃⁻ to CO₂ and for and intracellular . The remaining 10-20% is reabsorbed in the distal nephron, while new HCO₃⁻ is generated primarily in the cells through metabolism: is deaminated to glutamate and then α-ketoglutarate, yielding two molecules of (NH₄⁺) for urinary and two HCO₃⁻ ions that enter the . This process, along with titratable acid (e.g., buffering H⁺), allows net acid elimination and HCO₃⁻ addition, with full renal compensation developing over hours to days. The respiratory and renal mechanisms interplay to achieve integrated acid-base compensation, where acute respiratory changes precede and influence slower renal adjustments. For instance, in chronic (e.g., from raising PCO₂), the kidneys compensate by enhancing HCO₃⁻ reabsorption and generation, elevating plasma HCO₃⁻ to restore toward normal over 3-5 days. Hormonal factors modulate these renal processes: aldosterone, released via the renin-angiotensin-aldosterone system, promotes distal H⁺ secretion and NH₄⁺ excretion to generate new HCO₃⁻ during ; meanwhile, angiotensin II stimulates proximal HCO₃⁻ reabsorption by enhancing Na⁺/H⁺ exchange. This coordinated response ensures effective buffering against daily acid loads while preventing overcompensation.

Henderson-Hasselbalch Equation Application

The Henderson-Hasselbalch equation provides a mathematical framework for quantifying the pH of blood in the bicarbonate buffer system, derived from the dissociation equilibrium of carbonic acid: H₂CO₃ ⇌ H⁺ + HCO₃⁻. The acid dissociation constant is defined as K_a = \frac{[H^+][HCO_3^-]}{[H_2CO_3]}, where concentrations are in mmol/L. Taking the negative logarithm yields -\log[H^+] = -\log K_a + \log\left(\frac{[HCO_3^-]}{[H_2CO_3]}\right), or pH = pK_a + \log_{10}\left(\frac{[HCO_3^-]}{[H_2CO_3]}\right). This form was originally adapted by Hasselbalch for blood pH calculations involving bicarbonate and carbonic acid. In physiological conditions, [H₂CO₃] is low and primarily reflects dissolved CO₂, approximated by the solubility coefficient α (0.0301 mmol/L/mmHg at 37°C): [H₂CO₃] ≈ 0.03 × PCO₂, where PCO₂ is the partial pressure of CO₂ in mmHg. Substituting this approximation gives the standard physiological equation: pH = pK_a + \log_{10} \left( \frac{[HCO_3^-]}{0.03 \times PCO_2} \right) with pK_a ≈ 6.1 for carbonic acid at body temperature. Under normal conditions, [HCO₃⁻] = 24 mmol/L and PCO₂ = 40 mmHg, yielding pH = 6.1 + log(24 / (0.03 × 40)) = 6.1 + log(20) ≈ 7.4, maintaining arterial blood pH within the narrow range of 7.35–7.45. This equation enables prediction of pH shifts in acid-base disturbances. In respiratory acidosis, elevated PCO₂ (e.g., due to ) increases the denominator, lowering if [HCO₃⁻] remains constant; conversely, in respiratory alkalosis raises . In metabolic disturbances, reduced [HCO₃⁻] (e.g., from ) decreases the ratio and , while increased [HCO₃⁻] (e.g., from ) elevates it. These predictions assume rapid and help differentiate primary respiratory from metabolic causes. However, the equation has limitations in complex physiological scenarios. It assumes the bicarbonate system dominates buffering, neglecting contributions from non-bicarbonate buffers like , plasma proteins, and phosphates, which can alter effective by 0.1–0.2 units in severe disturbances. Additionally, it relies on assumptions, ignoring effects and activity coefficients in , leading to minor inaccuracies (up to 5–10%) at extreme values or low buffer concentrations. For a hypothetical case of uncompensated (e.g., with [HCO₃⁻] = 15 mmol/L and unchanged PCO₂ = 40 mmHg), the calculation proceeds as follows:
  1. Compute [H₂CO₃] ≈ 0.03 × 40 = 1.2 mmol/L.
  2. Determine the ratio [HCO₃⁻] / [H₂CO₃] = 15 / 1.2 = 12.5.
  3. Calculate log₁₀(12.5) ≈ 1.10.
  4. Add pK_a: pH ≈ 6.1 + 1.10 = 7.20, indicating moderate . This example illustrates how decreased [HCO₃⁻] directly lowers , guiding clinical intervention.

Kassirer-Bleich Approximation

The Kassirer-Bleich approximation provides a practical simplification of the Henderson-Hasselbalch equation for estimating acid-base parameters in the buffer system during clinical evaluations. Developed by John P. Kassirer and Howard L. Bleich in 1965, it was specifically intended for bedside use in the absence of calculators, enabling rapid calculations of concentration ([H⁺]), , of (PCO₂), or ([HCO₃⁻]) from two known variables. This approach stems from rearranging the Henderson-Hasselbalch equation while incorporating physiological constants, yielding the core relation [H⁺] (in nmol/L) ≈ 24 × PCO₂ (mmHg) / [HCO₃⁻] (mmol/L), where the constant 24 approximates normal values ([H⁺] = 40 nmol/L, PCO₂ = 40 mmHg, [HCO₃⁻] = 24 mmol/L). The derivation is based on the Henderson-Hasselbalch equation with pK_a ≈ 6.1 and incorporates the CO₂ solubility coefficient into the constant 24, allowing non-logarithmic computation of [H⁺] (in nmol/L) ≈ 24 × PCO₂ (mmHg) / [HCO₃⁻] (mmol/L), where the constant approximates normal values ([H⁺] = 40 nmol/L, PCO₂ = 40 mmHg, [HCO₃⁻] = 24 mmol/L). For changes from normal, this leads to the approximate form ΔpH ≈ log(Δ[HCO₃⁻]) - log(ΔPCO₂), where Δ denotes the ratio to baseline values (e.g., [HCO₃⁻]/24 and PCO₂/40); in metabolic perturbations with respiratory compensation, the pH shift simplifies further to ≈ 0.3 × log([HCO₃⁻]/24 mmol/L), reflecting the partial offset from ventilatory adjustments. These forms prioritize speed over precision, allowing clinicians to verify arterial blood gas consistency or predict compensatory responses without complex arithmetic. Key advantages include its utility in quick compensation assessments, such as estimating expected PCO₂ ≈ 0.7 × [HCO₃⁻] + 20 (±5 mmHg) in to evaluate if appropriately counters the rise. However, limitations arise in severe or mixed disorders, where assumptions like steady-state conditions fail, potentially leading to inaccuracies (e.g., in chronic , where [HCO₃⁻] normalization may fall within measurement error). As an example, in , the approximation aids in calculating renal compensation via the Δ[H⁺]/ΔPCO₂ ≈ 0.3. If PCO₂ increases acutely to 60 mmHg (ΔPCO₂ = 20 mmHg) without compensation, [H⁺] ≈ 24 × 60 / 24 = 60 nmol/L ( ≈ 7.22); with adaptation, [HCO₃⁻] rises by ≈ 3–4 mmol/L per 10 mmHg ΔPCO₂, yielding Δ[H⁺] ≈ 6 nmol/L ( ≈ 7.34), confirming appropriate buffering.

Roles in Other Biological Fluids

Buffering in Tear Fluid

The bicarbonate buffer system is essential for stabilizing the of tear , an externally exposed layer that interfaces with air and potential microbial contaminants. tear maintains a concentration of approximately 12.4 mM, notably lower than the 24-25 mM in , yet this level suffices to sustain a near-neutral of about 7.4 under open-eye conditions where of CO₂ (pCO₂) is reduced compared to closed-eye states. This adaptation ensures corneal protection without relying on the higher buffering capacity of systemic fluids. The buffering mechanism in tears relies on CO₂ diffusion from atmospheric air and the conjunctival vasculature into the tear film, facilitated by enzymes predominantly localized in the . These enzymes catalyze the rapid hydration of CO₂ to form , which dissociates into and protons, thereby neutralizing acid perturbations and restoring equilibrium. This process is critical for shielding the delicate corneal surface from acidic insults, such as those introduced by environmental pollutants or metabolic byproducts. Complementing the bicarbonate system, tear fluid features elevated levels of —an reaching 1-3 mg/mL, far higher than in most other secretions—and mucins that impart viscoelastic properties to the tear film, enhancing overall stability and barrier function. Disruptions to bicarbonate-mediated buffering, often linked to diminished lacrimal output, elevate risks for , where altered contributes to ocular discomfort, and , marked by corneal inflammation and epithelial damage. Studies on human tears have quantified buffering capacity, identifying a pronounced plateau around pH 7.0-7.7 attributable to , with intersubject variability underscoring adaptive physiological tuning.

Buffering in Cerebrospinal Fluid

The (CSF) maintains a concentration of approximately 21-22 mM, with a of (PCO₂) ranging from 40-45 mmHg and a around 7.32, rendering it slightly more acidic than arterial blood ( ~7.40). This composition supports the bicarbonate buffer system in CSF, where the lower total buffer capacity compared to arises primarily from the minimal protein content (15-45 mg/dL versus 6-8 g/dL in ), which reduces non-bicarbonate buffering. The absence of and lower concentrations of other proteins further limit CSF's ability to resist changes, making it more sensitive to respiratory influences. Regulation of the bicarbonate buffer in CSF is constrained by the blood-CSF barrier, which exhibits limited permeability to HCO₃⁻ ions, restricting direct equilibration with bicarbonate levels. Instead, CSF bicarbonate is primarily adjusted through active secretion by the epithelium, facilitated by sodium-bicarbonate cotransporters such as NBCe2, which are essential for normalization. , being highly diffusible, readily crosses the blood-CSF barrier via passive , allowing rapid adjustments to PCO₂ that influence CSF through the carbonic acid-bicarbonate . Consequently, the system responds more slowly to metabolic acid-base disturbances than to respiratory changes, as across the barrier lags behind CO₂ . The bicarbonate buffer in CSF plays a vital physiological role in safeguarding neuronal function by stabilizing extracellular against fluctuations that could disrupt enzymatic activity and potentials. This protective is particularly evident during , where elevated PCO₂ diffuses into CSF, initially acidifying it and potentially contributing to CO₂ narcosis—a state of —unless buffered by available HCO₃⁻. In contrast to , which benefits from extensive and higher buffering reserves, CSF relies predominantly on passive CO₂ equilibration and choroid plexus-mediated adjustments, underscoring its relative isolation from systemic .

Clinical and Diagnostic Aspects

Involvement in Acid-Base Disorders

The bicarbonate buffer system plays a central role in acid-base disorders, where disruptions in its lead to imbalances in blood , primarily through alterations in (HCO₃⁻) concentration or of (PCO₂). These disorders are classified as metabolic or respiratory based on whether the primary disturbance originates from changes in HCO₃⁻ or PCO₂ levels, respectively, and the system often attempts compensatory adjustments via the lungs or kidneys. Failures in respiratory or renal regulation can exacerbate these imbalances, resulting in clinical manifestations ranging from to life-threatening complications. Metabolic acidosis is characterized by a low HCO₃⁻ concentration, typically below 22 mEq/L, which decreases the capacity and leads to a drop in pH below 7.35. Common causes include accumulation of from tissue (), ketoacids in uncontrolled (), or gastrointestinal loss from , which depletes HCO₃⁻ without adding unmeasured anions. To distinguish (from added acids like or ketoacids) from normal anion gap types (like ), the is calculated as AG = Na⁺ - (Cl⁻ + HCO₃⁻), with a normal range of 8-12 mEq/L; elevated values indicate unmeasured anions. Metabolic alkalosis involves an elevated plasma HCO₃⁻ concentration above 28 mEq/L, raising pH above 7.45 and overwhelming the buffer system's acid-handling capacity. Primary causes include loss of gastric acid (hydrogen ions) from vomiting or nasogastric suction, and excessive renal bicarbonate retention due to diuretics like loop or thiazide agents, which promote chloride and volume depletion. These are further categorized as chloride-responsive (urine chloride <20 mEq/L, correctable with saline infusion, e.g., from vomiting) versus chloride-resistant (urine chloride >20 mEq/L, often due to mineralocorticoid excess like in primary hyperaldosteronism). Respiratory acidosis arises from , causing CO₂ retention and elevated PCO₂ above 45 mmHg, which shifts the bicarbonate equilibrium toward increased HCO₃⁻ production but results in net (pH <7.35) if uncompensated. Common etiologies include airway obstruction, neuromuscular disorders like Guillain-Barré syndrome, or sedative overdose, all impairing alveolar ventilation. Conversely, respiratory alkalosis occurs with hyperventilation, reducing PCO₂ below 35 mmHg and decreasing HCO₃⁻ via the buffer reaction, leading to pH >7.45; triggers include anxiety, from high altitude, or mechanical overventilation. Mixed acid-base disorders involve simultaneous or sequential disturbances in both metabolic and respiratory components, complicating diagnosis and compensation. For instance, in , a primary from ketoacids (low HCO₃⁻) is often accompanied by respiratory compensation through (Kussmaul respirations), lowering PCO₂ to mitigate the pH drop, though severe cases may show incomplete compensation. Recent refinements in anion gap assessment include correction for , as low (a major unmeasured anion) artificially lowers the gap by about 2.5-3 mEq/L per 1 g/dL decrease below 4 g/dL, potentially masking occult ; the corrected AG = observed AG + 2.5 × (4 - in g/dL).00623-5/fulltext)

Laboratory Assessment and Interpretation

The primary laboratory test for evaluating the bicarbonate buffer system in clinical settings is gas (ABG) analysis, which directly measures blood , partial pressure of (PCO₂), and concentration ([HCO₃⁻]), with [HCO₃⁻] often calculated from and PCO₂ using established relationships. ABG results provide essential data on the acid-base status, reflecting the ratio of [HCO₃⁻] to dissolved CO₂ as governed by the buffer dynamics. In addition, panels measure total CO₂ content, which primarily represents [HCO₃⁻] (accounting for about 90-95% of total CO₂) and serves as a surrogate for arterial levels when ABG is not immediately available. These tests are routinely performed in critical care, , and inpatient settings to monitor acid-base . Interpretation of ABG and related results begins with identifying the primary acid-base disorder by correlating with [HCO₃⁻] and PCO₂ values; for instance, a decreased pH (<7.35) accompanied by reduced [HCO₃⁻] (<22 mEq/L) signifies a primary metabolic acidosis driven by bicarbonate loss or acid accumulation. Subsequent steps involve assessing respiratory compensation, where the lungs adjust ventilation to normalize pH; in metabolic acidosis, the expected compensatory PCO₂ decrease is calculated using Winter's formula: expected PCO₂ (mmHg) = (1.5 × [HCO₃⁻]) + 8 ± 2, providing a benchmark to distinguish appropriate compensation from a mixed disorder. An approximate rule for this compensation is a PCO₂ drop of about 1.2 mmHg for every 1 mEq/L fall in [HCO₃⁻] below normal, aiding rapid clinical decision-making. These steps enable clinicians to detect uncompensated or partially compensated states, guiding interventions like bicarbonate administration or ventilatory support. Advanced analytical approaches, such as the Stewart method, offer an alternative to traditional bicarbonate-focused interpretation by quantifying the strong ion difference (SID)—the net charge difference between strong cations (e.g., Na⁺) and anions (e.g., Cl⁻)—alongside total weak acid concentration and PCO₂ as independent determinants of pH, revealing underlying electrolyte imbalances not apparent in standard ABG. Point-of-care (POC) ABG analyzers, used bedside for faster turnaround (often <5 minutes versus 20-30 minutes in central labs), may yield slightly lower [HCO₃⁻] and pH values compared to laboratory instruments due to differences in calibration and sample handling, but these discrepancies are typically within clinically acceptable limits (e.g., <0.03 for pH) and do not alter overall diagnosis in most cases. Recent updates in sepsis management, per the 2021 Surviving Sepsis Campaign guidelines, emphasize incorporating serum lactate measurement into routine panels alongside ABG for patients with suspected infection and elevated lactate (>2 mmol/L), as it indicates tissue hypoperfusion and guides targeted to normalize levels.

References

  1. [1]
    26.4 Acid-Base Balance – Anatomy & Physiology 2e
    The bicarbonate buffer is the primary buffering system of the IF surrounding the cells in tissues throughout the body. The respiratory and renal systems also ...
  2. [2]
    Acid–base balance: a review of normal physiology - PMC - NIH
    The bicarbonate system is important for two reasons. Firstly, it is the most plentiful buffer within the body; secondly, it acts as an open buffer system.
  3. [3]
    Properties of Blood as a Buffer and Blood Glucose
    The Carbonic Acid-Bicarbonate buffer system is the most important buffer for maintaining the pH homeostasis of blood. In this system, gaseous metabolic waste ...
  4. [4]
    Role of Carbonic Anhydrases and Inhibitors in Acid–Base Physiology
    Carbonic anhydrases (CAs) catalyze a reaction fundamental for life: the bidirectional conversion of carbon dioxide (CO2) and water (H2O) into bicarbonate (HCO3−) ...Missing: core | Show results with:core
  5. [5]
    Physiology, Carbon Dioxide Transport - StatPearls - NCBI Bookshelf
    Thus, bicarbonate is the primary means by which carbon dioxide is transported throughout the bloodstream according to the equation CO2 + H2O --> H2CO3 --> H+ + ...Missing: PCO2 | Show results with:PCO2
  6. [6]
    Kinetics of the Carbonic Acid System - aqion
    Nov 19, 2023 · Conventionally, the two species CO2(aq) and H2CO3 are treated together as if they were one substance (denoted by H2CO3*). Just this was done in ...
  7. [7]
    Predicting the safety and efficacy of buffer therapy to raise tumour pHe
    Mar 1, 2012 · ... pKa of bicarbonate in solution is 6.1, suggesting bicarbonate is a less effective buffer than a buffer with a pKa nearer to blood pH of 7.4.Missing: apparent | Show results with:apparent
  8. [8]
    Buffers and buffering power - Deranged Physiology
    Dec 18, 2023 · High concentration and correct pKa to be a good buffer system ... In summary, the bicarbonate buffer system is quantitatively the most important.Pka, The Negative Log Of The... · Extracellular Buffering · Haemoglobin As An...
  9. [9]
    Buffer capacities of human blood and plasma. - Semantic Scholar
    The buffer capacity of plasma proteins was found to be greater than that of bicarbonate at physiologic pH range and variations of buffer capacity caused by ...50 Citations · Blood Buffers: The Viewpoint... · Non-Carbonic Buffer Power Of...
  10. [10]
    Blood buffers: The viewpoint of a biochemist - PMC - NIH
    May 5, 2025 · The CO2/bicarbonate system contributes to a greater extent in vivo than in vitro because of its continuous production and excretion.
  11. [11]
    Physiology, Acid Base Balance - StatPearls - NCBI Bookshelf
    The human body experiences 4 main types of acid-based disorders: metabolic acidosis, metabolic alkalosis, respiratory acidosis, and respiratory alkalosis.
  12. [12]
    Arterial Blood Gas - StatPearls - NCBI Bookshelf
    Jan 8, 2024 · PaO2 (75-100 mm Hg). PaCO2 (35-45 mm Hg). HCO3 (22-26 mEq/L).
  13. [13]
    The respiratory system and acid–base disorders - ScienceDirect.com
    Within a few hours an abnormal blood pH also induces renal compensation. For example with a respiratory acidosis the kidneys will increase reabsorption of HCO3 ...Influence Of Carbon Dioxide... · Respiratory Acidosis · Alveolar Hypoventilation
  14. [14]
    Metabolic Acidosis in Chronic Kidney Disease - NIH
    Healthy kidneys can filter 4,500mEq of bicarbonate per day, and approximately 80% of the bicarbonate filtered through the glomerulus is reabsorbed in the ...
  15. [15]
    Renal Ammonia Metabolism and Transport - PMC - PubMed Central
    Quantitatively, metabolism of each glutamine molecule leads to generation of 2 NH4+ and 2 HCO3− ions when glutamine is metabolized through phosphate-dependent ...
  16. [16]
    The Role of the Endocrine System in the Regulation of Acid–Base ...
    Feb 19, 2024 · Hormones including aldosterone, angiotensin II, endothelin, PTH, glucocorticoids, insulin, thyroid hormone, and growth hormone can affect acid–base balance in ...
  17. [17]
    12.3: The Henderson–Hasselbalch Equation - Medicine LibreTexts
    Mar 13, 2024 · The balance of bicarbonate and hydrogen ions determines pH, and how both of these ions can be influenced by the kidneys and lungs to keep pH constant.
  18. [18]
    Henderson-Hasselbalch Equation | RK.MD
    May 19, 2020 · Based on the equation, as the bicarbonate concentration increases, so does the pH (more basic/alkaline), and as the pCO2 increases, the pH will ...
  19. [19]
    None
    ### Summary of Henderson-Hasselbalch Equation from Henderson.pdf
  20. [20]
    a critique of the Stewart and bicarbonate-centered approaches
    Jan 9, 2008 · ... equations simplify to the Henderson-Hasselbalch (H-H) equation only when a given solution contains bicarbonate but not other buffers. The ...
  21. [21]
  22. [22]
    [PDF] Chapter 15: Acid-Base Disorders
    Aug 7, 2018 · The Kassirer-Bleich equation may be used to estimate the concentration of any component of the bicarbonate buffer system provided the ...
  23. [23]
    Physiology, Metabolic Alkalosis - StatPearls - NCBI Bookshelf
    Expected pCO2 = 0.7 (HCO3) + 20 mmHg +/- 5. If the expected pCO2 does not match the measured value, an underlying metabolic alkalosis is a likely present.
  24. [24]
    Oxygen-deficient metabolism and corneal edema - PMC
    As discussed in Appendix B, the concentration of bicarbonate ion in the aqueous humor is set at 36 mM, whereas that in the TF is 12.4 mM for open-eye conditions ...
  25. [25]
    Environmental Conditions and Tear Chemistry - NCBI - NIH
    Tear fluid buffering is therefore important; this buffering is most often attributed to the bicarbonate system, but other mechanisms also likely contribute.
  26. [26]
    Immunohistolocalization and Gene Expression of the Carbonic ...
    Jan 13, 2010 · These reports suggest that tear fluid contains CA as a buffer, maintaining lacrimal pH to protect the surface of the corneal epithelia from ...
  27. [27]
    The microchemical detection of carbonic anhydrase in corneal ...
    Carbonic anhydrase (CA) activity has been detected and quantified in the corneal epithelia of various mammlian species using a microchemical assay.
  28. [28]
    The tear film and ocular mucins - PMC - PubMed Central
    Tears contain detectable levels of amino acids, bicarbonate, calcium, urea and magnesium. ... Lactoferrin has a high concentration in tears (65–160 mg/mL) ...<|control11|><|separator|>
  29. [29]
    Influence of tear fluid properties on physicochemical, mucoadhesion ...
    Overall, the mucoadhesion studies suggest that in DED, the tear fluid's more alkaline pH and high salt concentration, containing both positive and negative ions ...
  30. [30]
    The Lacrimal Gland and Its Veil of Tears | Physiology
    The secretion of these proteins is stimulated by the neurotransmitters and neuropeptides found in the neurons that innervate the gland. The acinar cells, ...
  31. [31]
  32. [32]
    Anion Gap and Non-Anion Gap Metabolic Acidosis - StatPearls - NCBI
    Aug 6, 2025 · Pathophysiology · The anion gap compares sodium concentration (and sometimes potassium) with the sum of chloride and bicarbonate concentrations.Introduction · Etiology · Pathophysiology · Treatment / Management
  33. [33]
    Metabolic Acidosis: Practice Essentials, Background, Etiology
    Sep 13, 2024 · The anion gap (AG) is the difference between the concentration of the major measured cation Na+ and the major measured anions Cl- and HCO3-. An ...Background · Renal Acid Handling · Etiology
  34. [34]
    Metabolic Alkalosis: Practice Essentials, Pathophysiology, Etiology
    Sep 9, 2024 · Causes of metabolic alkalosis can be divided into chloride-responsive alkalosis (urine chloride < 20 mEq/L), chloride-resistant alkalosis ...
  35. [35]
    Metabolic Alkalosis - Endocrine and Metabolic Disorders
    Metabolic alkalosis involving loss or excess secretion of Cl is termed chloride-responsive. The most common causes of chloride-responsive metabolic alkalosis ...
  36. [36]
    Respiratory Acidosis - StatPearls - NCBI Bookshelf
    In a state of hypoventilation, the body produces more CO2 than it can eliminate, causing a net retention of CO2. The increased CO2 is what leads to an increase ...
  37. [37]
    Respiratory Acidosis - Endocrine and Metabolic Disorders
    Respiratory acidosis is carbon dioxide (CO 2 ) accumulation (hypercapnia) due to a decrease in respiratory rate and/or respiratory volume (hypoventilation).
  38. [38]
    Respiratory Alkalosis: Background, Pathophysiology, Epidemiology
    Feb 18, 2025 · Respiratory alkalosis is a disturbance in acid and base balance due to alveolar hyperventilation. Alveolar hyperventilation leads to a decreased partial ...
  39. [39]
    Adult Diabetic Ketoacidosis - StatPearls - NCBI Bookshelf - NIH
    ... respiratory alkalosis is created to compensate for the metabolic acidosis of DKA. ... Diagnosis of mixed acid-base disorders in diabetic ketoacidosis. Am J Med ...
  40. [40]
    Biochemistry, Anion Gap - StatPearls - NCBI Bookshelf
    Every 1 g/L decrease in albumin will decrease the anion gap by 0.25 mmol/L. A patient with hypoalbuminemia may present with a normal anion gap when in ...